The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Self-citationEl-Khoueiry, A. B., Sangro, B., Yau, T., Crocenzi, T. S., Kudo, M., Hsu, C., Kim, T.-Y., Choo, S.-P., Trojan, J., Welling, T. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31046-2 · Cited by 4,280
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W.-J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,392
Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0105 · Cited by 2,222
Fourcade, J., Sun, Z., Benallaoua, M., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Kuchroo, V., & Zarour, H. M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100637 · Cited by 1,307
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Gros, A., Robbins, P. F., Yao, X., Li, Y. F., Turcotte, S., Tran, E., Wunderlich, J. R., Mixon, A., Farid, S., Dudley, M. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73639 · Cited by 1,111
Gao, Q., Qiu, S.-J., Fan, J., Zhou, J., Wang, X.-Y., Xiao, Y.-S., Xu, Y., Li, Y.-W., & Tang, Z.-Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,110
Sangro, B., Gomez-Martin, C., de la Mata, M., Iñarrairaegui, M., Garralda, E., Barrera, P., Riezu-Boj, J. I., Larrea, E., Alfaro, C., Sarobe, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.022 · Cited by 980
Kuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., & Zheng, L. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 903
Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003345107 · Cited by 859
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Baitsch, L., Baumgaertner, P., Devêvre, E., Raghav, S. K., Legat, A., Barba, L., Wieckowski, S., Bouzourene, H., Deplancke, B., Romero, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46102 · Cited by 845
Clinical blockade of PD1 and LAG3 — potential mechanisms of action
Nguyen, L. T., & Ohashi, P. S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3790 · Cited by 627
Li, H., Wu, K., Tao, K., Chen, L., Zheng, Q., Lu, X., Liu, J., Shi, L., Liu, C., Wang, G., et al. (2012) · Hepatology · doi:10.1002/hep.25777 · Cited by 496
Shi, F., Shi, M., Zeng, Z., Qi, R., Liu, Z., Zhang, J., Yang, Y., Tien, P., & Wang, F. (2011) · International Journal of Cancer · doi:10.1002/ijc.25397 · Cited by 464
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
da Silva, I. P., Gallois, A., Jimenez-Baranda, S., Khan, S., Anderson, A. C., Kuchroo, V. K., Osman, I., & Bhardwaj, N. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0171 · Cited by 424
Wu, K., Kryczek, I., Chen, L., Zou, W., & Welling, T. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0901 · Cited by 380
Fourcade, J., Sun, Z., Pagliano, O., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Olive, D., Kuchroo, V., & Zarour, H. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2637 · Cited by 372
Flecken, T., Schmidt, N., Hild, S., Gostick, E., Drognitz, O., Zeiser, R., Schemmer, P., Bruns, H., Eiermann, T., Price, D. A., et al. (2014) · Hepatology · doi:10.1002/hep.26731 · Cited by 351
Chew, V., Tow, C., Teo, M., Wong, H. L., Chan, J., Gehring, A., Loh, M., Bolze, A., Quek, R., Lee, V. K. M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.07.013 · Cited by 259
Legat, A., Speiser, D. E., Pircher, H., Zehn, D., & Fuertes Marraco, S. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00455 · Cited by 250
Germeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F., Lethé, B., De Plaen, E., Velu, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041379 · Cited by 232
Bonehill, A., Heirman, C., Tuyaerts, S., Michiels, A., Breckpot, K., Brasseur, F., Zhang, Y., van der Bruggen, P., & Thielemans, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6649 · Cited by 202
Self-citationvon Bergwelt-Baildon, M. S., Vonderheide, R. H., Maecker, B., Hirano, N., Anderson, K. S., Butler, M. O., Xia, Z., Zeng, W. Y., Wucherpfennig, K. W., Nadler, L. M., et al. (2002) · Blood · doi:10.1182/blood.v99.9.3319 · Cited by 192
Tricks with tetramers: how to get the most from multimeric peptide–MHC
Wooldridge, L., Lissina, A., Cole, D. K., Van Den Berg, H. A., Price, D. A., & Sewell, A. K. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02848.x · Cited by 184
Baitsch, L., Legat, A., Barba, L., Fuertes Marraco, S. A., Rivals, J.-P., Baumgaertner, P., Christiansen-Jucht, C., Bouzourene, H., Rimoldi, D., Pircher, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030852 · Cited by 184
Pedroza-Gonzalez, A., Verhoef, C., Ijzermans, J. N. M., Peppelenbosch, M. P., Kwekkeboom, J., Verheij, J., Janssen, H. L. A., & Sprengers, D. (2013) · Hepatology · doi:10.1002/hep.26013 · Cited by 172
Self-citationLissina, A., Ladell, K., Skowera, A., Clement, M., Edwards, E. S. J., Seggewiss, R., van den Berg, H. A., Emma Gostick, D., Gallagher, K., Jones, E., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.09.014 · Cited by 154
Li, F., Zhang, Y., Jin, G., Yao, L., & Wu, D. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.12.004 · Cited by 147
Coughlin, C. M., Vance, B. A., Grupp, S. A., & Vonderheide, R. H. (2003) · Blood · doi:10.1182/blood-2003-07-2379 · Cited by 140
Sideras, K., Biermann, K., Verheij, J., Takkenberg, R. B., Mancham, S., Hansen, B. E., Schutz, H. M., de Man, R. A., Sprengers, D., Buschow, S. I., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1273309 · Cited by 134
Self-citationHepatocellular carcinoma: Epidemiology and clinical aspects
Mazzanti, R., Gramantieri, L., & Bolondi, L. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.008 · Cited by 119
Pedroza‐González, A., Zhou, G., Vargas-Méndez, E., Boor, P. P. C., Mancham, S., Verhoef, C. K., Polak, W. G., Grünhagen, D. J., Pan, Q., Janssen, H. L. A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008355 · Cited by 114
Self-citationDolton, G. M., Lissina, A., Skowera, A., Ladell, K., Tungatt, K., Jones, E., Kronenberg‐Versteeg, D., Akpovwa, H., Pentier, J. M., Holland, C. J., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12339 · Cited by 105
Zhao, Q., Xiao, C., Wu, Y., Wei, Y., Zhu, L., Zhou, J., & Kuang, D. (2011) · European Journal of Immunology · doi:10.1002/eji.201041282 · Cited by 95
Sawada, Y., Yoshikawa, T., Shimomura, M., Iwama, T., Endo, I., & Nakatsura, T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2737 · Cited by 82
Yoshikawa, T., Nakatsugawa, M., Suzuki, S., Shirakawa, H., Nobuoka, D., Sakemura, N., Motomura, Y., Tanaka, Y., Hayashi, S., & Nakatsura, T. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01896.x · Cited by 81
Pedroza‐González, A., Zhou, G., Singh, S. P., Boor, P. P. C., Pan, Q., Grünhagen, D. J., de Jonge, J., Tran, T. K., Verhoef, C. K., IJzermans, J. N. M., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1051297 · Cited by 69
Self-citationBoor, P. P. C., Metselaar, H. J., de Jonge, S., Mancham, S., van der Laan, L. J. W., & Kwekkeboom, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201041229 · Cited by 66
Self-citationTumour antigen expression in hepatocellular carcinoma in a low-endemic western area
Sideras, K., Bots, S. J., Biermann, K., Sprengers, D., Polak, W. G., IJzermans, J. N. M., de Man, R. A., Pan, Q., Sleijfer, S., Bruno, M. J., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.92 · Cited by 52
Self-citationTCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets
Straetemans, T., van Brakel, M., van Steenbergen, S. C. L., Broertjes, M., Drexhage, J., Hegmans, J. P., Lambrecht, B. N., Lamers, C., van der Bruggen, P., Coulie, P. G., et al. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/586314 · Cited by 42
Shi, X.-L., de Mare-Bredemeijer, E., Tapirdamaz, Ö., Hansen, B. E., van Gent, R., van Campenhout, M. J. H., Mancham, S., Litjens, N. H. R., Betjes, M. G. H., van der Eijk, A. A., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13288 · Cited by 30
Self-citationNuffel, A. M. T. V., Tuyaerts, S., Benteyn, D., Wilgenhof, S., Corthals, J., Heirman, C., Neyns, B., Thielemans, K., & Bonehill, A. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.12.010 · Cited by 27
Self-citationGeneration of functional CD8+ T Cells by human dendritic cells expressing glypican-3 epitopes
O’Beirne, J. P., Farzaneh, F., & Harrison, P. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-48 · Cited by 25
Xu, Y., Li, H., Gao, R., Adeyemo, O., Itkin, M. G., & Kaplan, D. E. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.014 · Cited by 19
Cited by
Advances in immunotherapy for hepatocellular carcinoma
Sangro, B., Sarobe, P., Hervás-Stubbs, S., & Melero, I. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00438-0 · Cited by 1,306
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Donne, R., & Lujambio, A. (2023) · Hepatology · doi:10.1002/hep.32740 · Cited by 631
Lu, C., Rong, D., Zhang, B., Zheng, W., Wang, X., Chen, Z., & Tang, W. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1047-6 · Cited by 418
Systemic therapies for intrahepatic cholangiocarcinoma
Kelley, R. K., Bridgewater, J., Gores, G. J., & Zhu, A. X. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.009 · Cited by 412
Immune checkpoint therapy in liver cancer
Xu, F., Jin, T., Zhu, Y., & Dai, C. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0777-4 · Cited by 397
Metadata
- Authors
- Zhou, G., Sprengers, D., Boor, P. P. C., Doukas, M., Schutz, H., Mancham, S., Pedroza-Gonzalez, A., Polak, W. G., de Jonge, J., Gaspersz, M., Dong, H., Thielemans, K., Pan, Q., IJzermans, J. N. M., Bruno, M. J., & Kwekkeboom, J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 153
- Issue
- 4
- Pages
- 1107-1119.e10
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2664203916
- Cited by
- 412
- References
- 51
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.